These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15073939)

  • 1. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XII): collagen disorders and musculo-skeletal disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 Mar; 8(2):141-5. PubMed ID: 15073939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders.
    Bankowski Z
    Pharmacoepidemiol Drug Saf; 1998 Sep; 7(5):351-7. PubMed ID: 15073983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XIII): clinical pathology and general disorders.
    Council for International Organization of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 May; 8(3):217-24. PubMed ID: 15073931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic requirements for the use of terms for reporting adverse drug reactions (VIII): renal and urinary system disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1997 May; 6(3):203-11. PubMed ID: 15073789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (X): gastrointestinal system disorders.
    Pharmacoepidemiol Drug Saf; 1998 Jul; 7(4):281-7. PubMed ID: 15073991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1998 Jan; 7(1):39-49. PubMed ID: 15073745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group].
    Royer RJ; Benichou C
    Therapie; 1991; 46(3):173-8. PubMed ID: 1792648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia.
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):75-81. PubMed ID: 2026468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing requirements for the use of terms for reporting adverse drug reactions (ADR). Consultant, Council for International Organizations of Medical Sciences (CIOMS), World Health Organization.
    Mater Med Pol; 1993; 25(1):45-6. PubMed ID: 8412342
    [No Abstract]   [Full Text] [Related]  

  • 10. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.
    Benichou C; Solal Celigny P
    Nouv Rev Fr Hematol (1978); 1991; 33(3):257-62. PubMed ID: 1956763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing requirements for the use of terms for reporting adverse drug reactions.
    Venulet J
    Int J Clin Pharmacol Res; 1992; 12(2):61-4. PubMed ID: 1428299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Session of CIOMS (Council for International Organizations of Medical Sciences), Geneva, September 9-12, 1970].
    Horejsí J
    Cas Lek Cesk; 1970 Nov; 109(49):1153-4. PubMed ID: 5488975
    [No Abstract]   [Full Text] [Related]  

  • 14. Criteria of drug-induced liver disorders. Report of an international consensus meeting.
    Bénichou C
    J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge acquisition for computation of semantic distance between WHO-ART terms.
    Iavindrasana J; Bousquet C; Jaulent MC
    Stud Health Technol Inform; 2006; 124():839-44. PubMed ID: 17108617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmonizing the use of adverse-drug reaction terms. Definitions of terms and minimum requirements for their use: respiratory disorders and skin disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1997 Mar; 6(2):115-27. PubMed ID: 15073796
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Conference on Harmonisation; Guidance on E15 Pharmacogenomics Definitions and Sample Coding; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Apr; 73(68):19074-6. PubMed ID: 18677821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the knowledge and attitude to adverse drug reactions reporting among healthcare professionals in Wuhan city].
    Li Q; Zhang SM; Chen HT; Fang SP; Yu X; Liu D; Shi LY; Zeng FD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Oct; 25(10):894-7. PubMed ID: 15631751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.